Background As the life expectancy of people living with HIV increases with the
advancements in antiretroviral treatment, the continuity of long-term therapy and health care …

Background: Nelonemdaz is a multitarget neuroprotectant that selectively blocks N-methyl-D-
aspartate receptors and scavenges free radicals, as proven in preclinical ischemia …

Background Contemporary studies about HIV care continuum (HCC) outcomes within
substance using populations primarily focus on individual risk factors rather than provider-or …

Objective: To estimate the prevalence of HIV drug resistance over time and identify risk
factors for multiclass resistance. Design: Prospective clinical cohort of HIV-infected patients …

HIV disproportionately affects racial/ethnic minorities and individuals living in the southern
United States, and missed clinic visits account for much of this disparity. We sought to …

Objectives The aim of the study was to measure and compare national continuum of HIV
care estimates in Europe and Central Asia in three key subpopulations: men who have sex …

Quantifying HIV service provision along the HIV care continuum is increasingly important for
monitoring and evaluating HIV interventions. We examined factors associated with linkage …

Background Washington, DC, and sub-Saharan Africa are both affected by generalized HIV
epidemics. However, care for persons living with HIV (PLWH) and clinical outcomes may …

Background Delayed entry into HIV care has complicated the challenges faced in sub-
Saharan Africa due to the high HIV burden. A clear knowledge of the factors affecting …

Background: Among people living with HIV (PLHIV) enrolled into care, time to anti-retroviral
therapy (ART) has not been studied in Myanmar. To inform progress, we conducted this …